Humacyte Investor Relations Material
Latest events
Q1 2025
Humacyte
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Humacyte Inc
Access all reports
Humacyte Inc. is a clinical-stage biotechnology company developing regenerative medicine products. It focuses on bioengineered human tissues and organs for vascular and other applications. The company’s technology platform is designed to produce off-the-shelf, universally implantable tissues. The company is headquartered in Durham, North Carolina, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
HUMA
Country
🇺🇸 United States